سعر ابيكسول 0.5% قطرة عين 5 مل 2022

Betaxolol 0.5% eye drops (cardioselective beta-blocker for glaucoma/ocular hypertension), 5 ml bottle; Amman Pharmaceutical Co. (Jordan), distributed in Egypt by ADM for Trading & Projects.

• Lowering of intraocular pressure in ocular hypertension and chronic open-angle glaucoma, alone or with other anti-glaucoma drugs.Population: AdultsDailyMed (U.S. National Library of Medicine)

• Ocular: brief discomfort in about one in four patients, occasional tearing; rarely decreased corneal sensitivity, erythema, itching, corneal punctate staining, keratitis, anisocoria, oedema and photophobia.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Systemic (rare): bradycardia, heart block, congestive heart failure, pulmonary distress (dyspnoea, bronchospasm, asthma, respiratory failure), insomnia and dizziness.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to any component; sinus bradycardia, greater than first-degree atrioventricular block, cardiogenic shock, or overt cardiac failure.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Topically applied beta-blockers may be absorbed systemically; severe respiratory (bronchospasm in asthma) and cardiac reactions, including death, have been reported with topical beta-blockers. Use caution in cardiac failure or heart block and discontinue at the first signs of cardiac failure.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Use with caution in patients with severe reactive airway disease/asthma or restricted pulmonary function, diabetes or spontaneous hypoglycaemia (may mask hypoglycaemia), suspected thyrotoxicosis (avoid abrupt withdrawal), myasthenic symptoms, before major surgery, and in patients with a history of severe anaphylaxis (may be unresponsive to usual epinephrine doses).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Oral beta-adrenergic blockersPotential additive effect on intraocular pressure or on systemic beta-blockade; observe the patient.DailyMed (U.S. National Library of Medicine)
• Catecholamine-depleting drugs (e.g. reserpine)Possible additive hypotension and/or bradycardia; close observation recommended.DailyMed (U.S. National Library of Medicine)
• Adrenergic psychotropic drugsUse caution with concomitant adrenergic psychotropic drugs.DailyMed (U.S. National Library of Medicine)

• No adequate and well-controlled studies in pregnant women; oral betaxolol caused post-implantation loss in rats and rabbits at high doses but was not teratogenic. Use in pregnancy only if the potential benefit justifies the potential risk to the fetus.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Not known whether betaxolol is excreted in human milk; use caution in nursing women.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Betaxolol: Cardioselective beta-1-adrenergic blocker that, when instilled in the eye, reduces elevated as well as normal intraocular pressure (US label).